Published ahead of print on January 25, 2007, doi:10.1164/rccm.200607-969OC
© 2007 American Thoracic Society doi: 10.1164/rccm.200607-969OC
Cured Meat Consumption, Lung Function, and Chronic Obstructive Pulmonary Disease among United States Adults1 Division of General Medicine, Department of Medicine, and 2 Department of Ophthalmology, College of Physicians and Surgeons, Columbia University, New York, New York; 3 Hankinson Consulting, Valdosta, Georgia; and 4 Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York Correspondence and requests for reprints should be addressed to R. Graham Barr, M.D., Dr.P.H., Columbia University Medical Center, 622 West 168th Street, PH 9 EastRoom 105, New York, NY 10032. E-mail: rgb9{at}columbia.edu
Rationale: Cured meats are high in nitrites. Nitrites generate reactive nitrogen species that may cause nitrative and nitrosative damage to the lung resulting in emphysema. Objective: To test the hypothesis that frequent consumption of cured meats is associated with lower lung function and increased odds of chronic obstructive pulmonary disease (COPD). Methods: Cross-sectional study of 7,352 participants in the Third National Health and Nutrition Examination Survey, 45 years of age or more, who had adequate measures of cured meat, fish, fruit, and vegetable intake, and spirometry.
Results: After adjustment for age, smoking, and multiple other potential confounders, frequency of cured meat consumption was inversely associated with FEV1 and FEV1/FVC but not FVC. The adjusted differences in FEV1 between individuals who did not consume cured meats and those who consumed cured meats 1 to 2, 3 to 4, 5 to 13, and 14 or more times per month were 37.6, 11.5, 42.0, and 110 ml, respectively (p for trend < 0.001). Corresponding differences for FEV1/FVC were 0.91, 0.54, 1.13, and 2.13% (p for trend = 0.001). These associations were not modified by smoking status. The multivariate odds ratio for COPD (FEV1/FVC Conclusions: Frequent cured meat consumption was associated independently with an obstructive pattern of lung function and increased odds of COPD. Additional studies are required to determine if cured meat consumption is a causal risk factor for COPD.
Key Words: cured meats nitrites lung function chronic obstructive pulmonary disease emphysema
Chronic obstructive pulmonary disease (COPD) is currently the fourth leading cause of death in the United States (1, 2). The death rate from COPD doubled between 1970 and 2002, in contrast to an overall decline in mortality in the United States (3). COPD prevalence and mortality continue to rise, such that COPD is projected to become the third leading cause of death worldwide by 2020 (4). Despite the magnitude of the problem, preventive strategies for COPD are limited to avoidance of cigarette smoking. Nitrites generate reactive nitrogen species that may cause nitrative and nitrosative damage to the lung, producing structural changes resembling emphysema. In 1968, a rodent model of experimental emphysema was described in which rats exposed to 10 to 25 ppm of ambient nitrogen dioxide (NO2, a nitrite gaseous precursor) developed emphysematous changes in their lungs (57). In 1972, Shuval and Gruener added 1,000 to 3,000 mg/L sodium nitrite to the drinking water of rats for a 2-year period (8). The authors intended to study the carcinogenic effects of long-term nitrite intake, which leads to production of nitrosamine and nitrosamide compounds, but instead observed dilated coronary arteries and pulmonary emphysema. Cured meats, such as bacon, sausage, luncheon meats, and cured hams, are high in nitrites, which are added to meat products as a preservative, an antimicrobial agent, and a color fixative (9). Although these rodent studies suggest that inhalation of NO2 and ingestion of sodium nitrite may contribute to emphysema, no human studies have examined the relationship between consumption of cured meats and COPD. We therefore tested the hypothesis that frequent consumption of cured meats would be associated with an obstructive pattern of spirometry and increased odds of COPD in a large, representative sample of U.S. adults. Some results in this article were presented in abstract form at the 2006 meeting of the European Respiratory Society (10).
Study Population The Third National Health and Nutrition Examination Survey (NHANES III) was a cross-sectional survey conducted from 1988 through 1994 by the National Center for Health Statistics. Approximately 33,994 noninstitutionalized U.S. civilians aged 2 months or older were selected via a stratified multistage probability sampling design. Detailed description of the methodology of NHANES III has been previously published (11, 12). For the present study, we restricted the sample to 9,787 participants aged 45 years or older because COPD is rare before that age and because the association of cured meat and COPD is less likely to be subject to misclassification with asthma. We excluded participants who were missing measures of cured meat consumption (n = 38), fish, fruit, or vegetable consumption (n = 80), or lung function (n = 2,143). One author (J.L.H.) supervised measurement of spirometry in NHANES III, reviewed all spirometry results, and excluded a further 174 participants who did not have acceptable spirometry curves.
Dietary Assessment
Outcome Assessment
We defined COPD for this study a priori as prebronchodilator FEV1/FVC
Statistical Analysis
The study sample included 7,352 NHANES III participants 45 years of age or older with adequate information on meat consumption and lung function. The mean age was 64.5 years and 48.0% were male. Those excluded because of missing measures of cured meat, fish, fruit and vegetable consumption, or lung function were older (mean age = 71.0 yr) and had a higher prevalence of physician-diagnosed emphysema or chronic bronchitis (12.8 vs. 9.54% in the study sample). The distributions of sex, race/ethnicity, and smoking status were similar between the two groups. Those missing lung function data had cured meat consumption similar to participants in the study sample.
The study sample represented 68.2 million adults aged 45 years or older in the United States. The characteristics of this population, stratified by frequency of cured meat consumption are shown in Table 1. Individuals who consumed cured meats frequently were more likely to be male, of lower socioeconomic status, and tobacco users, and were less likely to report physician-diagnosed asthma than individuals who never consumed cured meats. Those who consumed cured meats more frequently had lower intakes of vitamin C,
Greater frequency of cured meat consumption was associated with lower FEV1, FVC, and FEV1/FVC after adjustment for demographics and height (Table 2, model 1). After controlling for smoking status, pack-years, cotinine levels, and household environmental tobacco smoke (ETS) exposure, these inverse associations were attenuated, but remained statistically significant (Table 2, model 2). After simultaneous adjustment for multiple additional confounding variables, individuals who ate cured meat consumption 14 times/month or more had a significantly lower FEV1 (110 ml; p for trend < 0.001) and FEV1/FVC (2.13%; p for trend < 0.001) compared with those who never ate cured meats. FVC did not differ significantly across categories of cured meat consumption. Each time-per-month increase in cured meat consumption was associated with a 3.85 ml decrease in FEV1 and 0.07% decrease in FEV1/FVC. The frequency of cured meat consumption was positively associated with odds of COPD (Table 3). The OR for COPD among individuals who consumed cured meat 14 times or more per month was 1.93 (95% confidence interval [CI], 1.412.64; p for trend = 0.001) compared with those who did not consume cured meats, after adjustment for age, sex, race/ethnicity, height, and smoking variables. Further adjustment for other confounding variables yielded similar results. Each time-per-month increase in cured meat consumption was associated with a 2% increased risk for COPD (multivariate OR, 1.02; 95% CI, 1.011.03). Figure 1 shows a monotonic increase in OR for mild, moderate, severe, and severe or very severe COPD across these categories. Severe and very severe COPD categories were combined because of the small number of participants with very severe COPD (n = 34) in this study. The separate ORs were 2.51 for severe COPD and 352 for very severe COPD; both ORs were statistically significant.
The sensitivity analysis using the LLN definition of COPD (FEV1/FVC < [FEV1/FVC]LLN and FEV1< [FEV1]LLN) yielded similar results (15). The multivariate-adjusted OR for COPD in this analysis was 1.67 (95% CI, 1.042.69; p for trend = 0.01) comparing the highest to the lowest category of cured meat consumption after adjustment for all the potential confounding factors. Multivariate analyses stratified by smoking status showed that the inverse associations of cured meat consumption with FEV1 and FEV1/FVC persisted among 2,823 never-smokers, 2,155 past smokers, and 1,929 current smokers (Table 4), although the standard threshold of statistical significance was not met for current smokers. There was no apparent modification of the relations between cured meat consumption and lung function by smoking status (p for interaction was 0.64 for FEV1, 0.94 for FVC, and 0.66 for FEV1/FVC).
Consumption of ham and pork (e.g., cured and noncured meats, respectively) was inversely associated with lung function but these associations did not attain statistical significance. The multivariate differences between individuals consuming ham and pork five times or more per month (the highest two categories were combined because of less consumption of ham and pork) and those who never ate cured meats were 40.1 ml (p = 0.12) for FEV1, 49.7 ml (p = 0.09) for FVC, and 0.11% (p = 0.82) for FEV1/FVC. The multivariate OR for COPD comparing the two extreme categories (highest vs. lowest) of ham and pork consumption was 1.18 (95% CI, 0.801.73). According to the ATS standard, we did not exclude participants with a nonreproducible test from the study. Sensitivity analyses for cured meats excluding 104 individuals with only one acceptable curve (n = 7,248) showed similar differences in lung function and in risk of COPD in the main analyses. Compared with those who did not consume cured meats, individuals who consumed cured meats 14 times or more per month had a significantly lower FEV1 (107 ml; p for trend < 0.001) and FEV1/FVC (2.08%; p for trend < 0.001) after adjustment for all the potential confounders. The multivariate OR for COPD comparing the highest to the lowest category of cured meat consumption was 1.78 (95% CI, 1.282.46) in this sensitivity analysis.
This study of a representative sample of U.S. population aged 45 years or older showed that frequent consumption of cured meats was associated with lower FEV1 and FEV1/FVC and an increased odds of COPD after adjustment for multiple known risk factors. The magnitude of the risk of COPD increased with severity of COPD. Cured meats may contribute to the development of COPD because of their high content of nitrites (9, 19). Nitrites are prooxidants and are involved in the formation of reactive nitrogen species that include both nitrating (i.e., NO2) as well as nitrosating (i.e., nitrosonium + NO or dinitrogen trioxide [N2O3]) agents (20, 21). Reactions of nitrite with H2O2/myeloperoxidase (22), H2O2/Fe2+ (23), and H2O2/hypochlorous acid (24) all result in protein tyrosine nitration. 3-Nitro-tyrosine, which has been used as a biomarker for studying disease states associated with nitrative/nitrosative stress, is elevated in the inflammatory cells (25) and bronchial submucosa (26) of patients with COPD, suggesting that nitrating and nitrosating reactions may be increased in COPD. Paik and colleagues showed that nitrating and nitrosating reactions induce extracellular matrix protein changes that include covalent nonenzymatic collagen cross-linking (27, 28) and elastin fragmentation in model system experiments paralleling the aging/diabetes model system of nonenzymatic glycation (29). Such in vitro findings are pertinent to COPD because both biochemical and histopathologic studies indicate that collagen and elastin damage occurs during the development of human pulmonary emphysema (3032). These findings are also consistent with animal studies that demonstrated that rats fed long term with dietary nitrite developed dilated coronary arteries and pulmonary emphysema (8). Elastin and collagen integrity are principally responsible for the maintenance of both long-term coronary vessel diameter and alveolar airspace size, suggesting that supraphysiologic nitrite supplementation damages the connective tissue matrix. Although these experimental and animal studies suggest that nitrite exposure may cause lung damage through its effects on connective tissues in the lung, this is the only article of which we are aware that has examined the association between a principal source of dietary nitrite, cured meat intake, with lung function or COPD in humans.
Tobacco smoke is another major source of nitrite in the body. Of the approximately 4,000 different compounds in tobacco smoke, several compounds are present in relatively high amounts and include carbon monoxide, nicotine, and nitrogen oxides (NOx) (33). NOx comprise mainly nitric oxide (NO) and NO2, and almost all of the NOx inhaled in cigarette smoke are retained in the body (34). NOx gas is converted exclusively to nitrite
Prior epidemiologic studies have reported an inverse association between intake of fish, fruits, vegetables, and antioxidant vitamins (e.g., vitamins C and E, The major strength of this study was its large representative sample and multiple measures of smoking, including serum cotinine levels and ETS exposure. A limitation of the study was its cross-sectional design, which may introduce reverse causation and selection bias. Reverse causation was unlikely in that COPD probably did not cause participants to increase their cured meat consumption. Selection bias was minimized by the population-based, representative sampling of NHANES III participants. Cross-sectional studies of lung function can also yield different results from longitudinal studies of lung function for other reasons, including effect size, which was modest in this study. Smoking is the primary cause of COPD, so residual confounding by smoking was a potential concern. We adjusted, however, not only for self-report of smoking status, pack-years, and household ETS but also for serum cotinine levels as a biomarker of current smoking dose and current ETS exposure. In addition, we used cotinine levels to correct self-reported smoking status. Finally, the lack of effect modification by smoking status of the association of cured meats with lung function and the statistically significant inverse associations among never-smokers suggested true independent associations. We cannot rule out the possibility that unmeasured aspects of an unhealthy lifestyle may have caused the lower lung function and increased risk of COPD in those who ate cured meats frequently, although we adjusted for multiple dietary variables considered to be correlated with cured meat consumption in our multivariate analyses. We also lacked robust measures of dietary nitrite intake, post-bronchodilator lung function, and occupational exposures. Because food intake was self-reported and cured meats with varying nitrite content were grouped together in NHANES III, misclassification of nitrite consumption was inevitable and could bias the observed associations. Lack of post-bronchodilator measures can inflate prevalence estimates of COPD (39), but was unlikely to affect our results unless bronchodilator responsiveness was appreciably greater in those with high cured meat consumption. However, self-reported asthma was less frequent in those with high cured meat consumption, and we used relatively conservative definitions of COPD in the main and sensitivity analysis. In conclusion, frequent cured meat consumption was associated with an obstructive pattern of lung function and increased odds of COPD independent of other major risk factors. High dietary nitrite intake warrants further evaluation in prospective, longitudinal studies as a novel risk factor for COPD.
Supported by research grants HL075476, HL077612, and K08-AG000863 from the National Institutes of Health. This article has an online supplement, which is accessible from this issue's table of contents at www.atsjournals.org Originally Published in Press as DOI: 10.1164/rccm.200607-969OC on January 25, 2007 Conflict of Interest Statement: None of the authors has a financial relationship with a commercial entity that has an interest in the subject of this manuscript. Received in original form July 17, 2006; accepted in final form January 24, 2007
This article has been cited by other articles:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||